iRhythm Holdings, Inc. Common Stock
IRTCStock
$115.35−15.43%52W
Market Cap$3.76B
P/E—
Div yield—
Beta1.32
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-49.02%
Price vs S&P 500 (4W)3.46%
VGM Score46.56
Market Capitalization$3.76B
Earnings Surprise History
Q1 26-0.35est. -0.66
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.33
4.33
4.33
4.33
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IRTCiRhythm Holdings, Inc. Common Stock | D | A | D | $115.35 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
iRhythm Holdings develops and commercializes the Zio System, an FDA-cleared digital platform for ambulatory cardiac monitoring that combines a wire-free, wearable biosensor with proprietary cloud-based analytics software. The system enables clinicians to diagnose arrhythmias more quickly and efficiently than traditional monitoring methods by continuously recording electrocardiogram data over 14 days. Designed for improved diagnostic accuracy and clinical efficiency, Zio addresses a key need in cardiac care monitoring.